Evidence map›Paper›PMID 32661617›Full record

ArticleInternational urology and nephrology2020

MiR-194 targets Runx1/Akt pathway to reduce renal fibrosis in mice with unilateral ureteral obstruction.

Li Cheng, Can Tu, Yonglong Min, Da He, Sheng Wan, Fei Xiong

Abstract read
PubMed Publisher
In one paragraph

Article in International urology and nephrology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. RUNX1 promotes liver fibrosis progression through regulating TGF-β signalling.International journal of experimental pathology · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Li ChengDepartment of Nephrology, Hubei Province, Wuhan No. 1 Hospital, 215# Zhongshan Avenue, Wuhan, 430022, China.
Can TuDepartment of Nephrology, Hubei Province, Wuhan No. 1 Hospital, 215# Zhongshan Avenue, Wuhan, 430022, China.
Yonglong MinDepartment of Nephrology, Hubei Province, Wuhan No. 1 Hospital, 215# Zhongshan Avenue, Wuhan, 430022, China.
Da HeDepartment of Nephrology, Hubei Province, Wuhan No. 1 Hospital, 215# Zhongshan Avenue, Wuhan, 430022, China.
Sheng WanDepartment of Nephrology, Hubei Province, Wuhan No. 1 Hospital, 215# Zhongshan Avenue, Wuhan, 430022, China.
Fei XiongDepartment of Nephrology, Hubei Province, Wuhan No. 1 Hospital, 215# Zhongshan Avenue, Wuhan, 430022, China. FeiXiongset@163.com.ORCID http://orcid.org/0000-0002-6078-3049
Wuhan No.1 Hospital · CNWuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeChronic kidney disease (CKD) has become a global public health problem and accompanied by renal fibrosis. MiR-194, a tumor suppressor gene, has been previously reported to be associated with the pathogenesis of tissue fibrosis. However, the role of miR-194 in the pathogenesis of renal fibrosis remains unknown.

methodsA renal fibrosis model was constructed by unilateral ureteral obstruction (UUO) in male C57BL/6 mice. HE and MASSON stainings were used for histological analysis. The expression level of miR-194 was detected by RT-qPCR. The protein expression was detected by western blotting. The levels of inflammatory cytokines were detected by ELISA. The relationship between miR-194 and Runx1 was further verified by dual luciferase reporter assay.

resultsThe results showed that miR-194 level was downregulated in kidney tissue of UUO mice, accompanied by significantly pathological damage and renal fibrosis. MiR-194 mimics significantly reduced pathological damage and alleviated renal fibrosis that caused by UOO, and inhibited the expression levels of α-SMA and collagen I. In addition, miR-194 mimics also reduced the expression level of serum inflammatory factors. Moreover, in vitro analysis indicated that Runx1 was a downstream target gene of miR-194. Furthermore, mechanism analysis indicated that miR-194 reduced mouse renal fibrosis by inhibiting the Runx1/AKT pathway in vivo and in vitro.

conclusionThe present findings suggested that miR-194 targets Runx1/Akt pathway to reduce renal fibrosis in UOO-induced mice. This study provides a novel strategy for the prevention and treatment of renal fibrosis.

Indexed as

AnimalsCore Binding Factor Alpha 2 SubunitFibrosisKidneyMaleMiceMice, Inbred C57BLMicroRNAsOncogene Protein v-aktSignal TransductionUreteral ObstructionCore Binding Factor Alpha 2 SubunitMicroRNAsMIRN194 microRNA, mouseOncogene Protein v-aktRunx1 protein, mouseInflammationmiR-194Protein kinase BRenal fibrosisRunt-related transcription factor 1

Identifiers

PMID32661617
OpenAlexW3042290041

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.